MS-STAT2 trial results

We’re proud to have co-funded this phase 3 trial testing if simvastatin can slow progression in secondary progressive MS.

Thank you for taking part in the trial. Without you, research like this wouldn’t be possible.

Principal investigator Professor Jeremy Chataway has recorded a message to explain the results of the trial. You’ll also hear from Caroline Wyatt, who took part in the trial, and Dr Emma Gray, our Assistant Director of Research.

You can also learn more about the results in our news story.

You may also be interested in

What we're doing about progressive MS

As more research into understanding and treating progressive MS happens, there's real hope of finding new treatments.

“We have the wonderful participants to thank” – Simvastatin trial completes recruitment

The 964th person with MS has now joined the MS-STAT2 trial. So Professor Jeremy Chataway and his team have met their recruitment goal and we should have the results in 2025.

My quality of life has improved thanks to MS Society research

Stuart Wood, from County Durham, is 53 and lives with secondary progressive MS. He features in our BBC Lifeline Appeal alongside his wife Sharon and daughter Lucy, who was diagnosed with MS when she was just 5-years-old. He told us about the impact our research has had on his quality of life.

MS-STAT2 trial results

You may also be interested in

What we're doing about progressive MS

“We have the wonderful participants to thank” – Simvastatin trial completes recruitment

My quality of life has improved thanks to MS Society research

The next research breakthrough is in reach